The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials. [electronic resource]
Producer: 20190403Description: 117-122 p. digitalISSN:- 1877-783X
- Antineoplastic Agents -- therapeutic use
- Biomedical Research
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase III as Topic
- Female
- Humans
- Male
- National Cancer Institute (U.S.)
- Periodicals as Topic -- statistics & numerical data
- Prostatic Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
- Survival Rate
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.